Similar articles

• [Monoamine oxidase and its inhibitors. Physiological, physiopathological and pharmacotherapeutic considerations].

  Constantinescu I. Constantinescu I. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir. 1978 Oct-Dec;23(4):303-12. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir. 1978. PMID: 370952 Review. Romanian. No abstract available.
• Monoamine oxidase, monoamine oxidase inhibitors, and panic disorder.

  Norman TR, Burrows GD. Norman TR, et al. J Neural Transm Suppl. 1989;28:53-63. J Neural Transm Suppl. 1989. PMID: 2677243 Review.
• Monoamine oxidase. Its inhibition.

  Youdim MB. Youdim MB. Mod Probl Pharmacopsychiatry. 1975;10:65-88. Mod Probl Pharmacopsychiatry. 1975. PMID: 1101049 Review.
• Monoamine oxidase and cigarette smoking.

  Fowler JS, Logan J, Wang GJ, Volkow ND. Fowler JS, et al. Neurotoxicology. 2003 Jan;24(1):75-82. doi: 10.1016/s0161-813x(02)00109-2. Neurotoxicology. 2003. PMID: 12564384 Review.
• Acute versus chronic effects of monoamine oxidase inhibitors in depressed patients: time course of MAO inhibitors [proceedings].

  Robinson DS, Nies A, Ravaris CL. Robinson DS, et al. Psychopharmacol Bull. 1977 Jan;13(1):50-1. Psychopharmacol Bull. 1977. PMID: 319474 Clinical Trial. No abstract available.